OPPORTUNITY TO CONTROL ASTHMA: A ROLE OF SMALL AIRWAYS
https://doi.org/10.18093/0869-0189-2011-0-2-101-108
Abstract
Opportunity to control asthma: a role of small airways
About the Authors
A. V. Budnevsky
ИПМО ГОУ ВПО "Воронежская государственная медицинская академия им. Н.Н.Бурденко МЗ и СР"
Russian Federation
Russian Federation
д. м. н., проф. кафедры общей врачебной практики (семейной медицины),глав.внештат. пульмонолог УЗ г. Воронежа
394036, Воронеж, ул. Студенческая, 10
тел.: +7 (4732) 52-03-80
V. T. Burlachuk
ИПМО ГОУ ВПО "Воронежская государственная медицинская академия им. Н.Н.Бурденко МЗ и СР"
Russian Federation
Russian Federation
д. м. н., проф., зав. кафедрой общей врачебной практики (семейной медицины),глав. внештат. пульмонолог ДЗ Воронежской области
394036, Воронеж, ул. Студенческая, 10
I. A. Olysheva
ИПМО ГОУ ВПО "Воронежская государственная медицинская академия им. Н.Н.Бурденко МЗ и СР"
Russian Federation
Russian Federation
аспирант кафедры общей врачебной практики (семейной медицины)
394036, Воронеж, ул. Студенческая, 10
E. V. Tokmachev
ИПМО ГОУ ВПО "Воронежская государственная медицинская академия им. Н.Н.Бурденко МЗ и СР"
Russian Federation
Russian Federation
ассистент кафедры общей врачебной практики (семейной медицины)
394036, Воронеж, ул. Студенческая, 10
References
1. Beasley R. The Global Burden of Asthma Report, Global Initiative for Asthma (GINA). Available from http:// www.ginasthma.org; 2004.
2. Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59 (5): 469–478.
3. Bousquet J., Jeffery P.K., Busse W.W. et al. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 2000; 161 (5): 1720–1745.
4. Cohn L., Elias J.A., Chupp G.L. Asthma: mechanisms of disease persistence and progression. Ann. Rev. Immunol. 2004; 22:789–815.
5. GINA Report, Global Strategy for Asthma Management and Prevention. Updated December 2009.
6. Vignola A.M., Mirabella F., Costanzo G. et al. Airway remodeling in asthma. Chest 2003; 123: 417–422.
7. Royce S.G., Tang M.L. The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention. Curr. Mol. Pharmacol.; 2009; 2 (2): 169–181.
8. Saetta M., Di Stefano A., Rosina C. et al. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am. Rev. Respir. Dis.; 1991; 143: 138–143.
9. Corren J. Small airways disease in asthma. Curr. Allergy Asthma Rep. 2008; 8: 533–539.
10. Tulic M.K., Christodoulopoulos P., Hamid Q. Small airway inflammation in asthma. Respir. Res. 2001; (2): 333–339.
11. Яшина Л.А. Особенности бронхиальной астмы с тяжелым течением. Здоровье Украины 2010; 1: 6–8.
12. Contoli M., Bousquet J., Fabbri L.M. et al. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy 2010; 65 (2): 141–151.
13. Гриппи М.А. Патофизиология легких. М.: Восточная книжная компания; 1997.
14. Турина О.И., Лаптева И.М., Калечиц О.М. и др. Организация работы по исследованию функционального состояния легких методами спирографии и пневмотахографии и применение этих методов в клинической практике: Методические указания. Минск; 2002.
15. Booker R. Interpretation and evaluation of pulmonary function tests. Nurs. Stand. 2009; 23: 46–56.
16. Schneider A., Gindner L., Tilemann L. et al. Diagnostic accuracy of spirometry in primary care. BMC Pulm. Med. 2009; 10:9–31.
17. Miller M.R., Hankinson J., Brusasco V. et al. Standardisation of spirometry. Series "ATS / ERS task force: standardisation of lung function testing". Eur. Respir. J. 2005; 26: 319–338.
18. Kraft M., Cairns C.B., Ellison M.C. et al. Improvements in distal lung function correlate with asthma symptoms after treatment with oral Montelukast. Chest 2006; 130: 1726–1732.
19. Полянская М.А. Бодиплетизмография и исследование DLCO – методика проведения и интерпретация результатов. Здоровье Украины 2008; 9 (1): 52–53.
20. Ярцев С.С. Структурный анализ диагностической эффективности показателей бодиплетизмографии у больных бронхиальной астмой. Медицинская техника 2005; 3:21–23.
21. Levitzky M.G. Pulmonary physiology. 7th ed. New York: McGraw-Hill Medical; 2007.
22. Яшина Л.А., Полянская М.А., Загребельный М.Р. Импульсная осциллометрия – новые возможности в диагностике и мониторинге обструктивных заболеваний легких. Здоровье Украины 2009; 23 (1): 26–27.
23. Kaminsky D.A., Irvin C.G., Lundblad L. et al. Oscillation mechanics of the human lung periphery in asthma. J. Appl.Physiol. 2004; 97: 1849–1858.
24. Winkler J., Hagert-Winkler A., Wirtz H. et al. Impulse oscillometry in the diagnosis of the severity of obstructive pulmonary disease. Pneumologie 2009; 63 (5): 266–275.
25. Goldman M.D. Clinical application of forced oscillation. Pulm.Pharmacol. Ther. 2001; 14: 341–350.
26. Bourdin A., Paganin F., Prefaut C. et al. Nitrogen washout slope in poorly controlled asthma. Allergy 2006; 61: 85–89.
27. in't Veen J.C., Beekman A.J., Bel E.H., Sterk P.J. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes Am. J. Respir. Crit. Care Med. 2000; 161: 1902–1906.
28. Magnussen H., Holz O. Monitoring airway inflammation in asthma by induced sputum. Eur. Respir. J. 1999; 13: 5–7.
29. Tsoumakidou M., Tzanakis N., Siafakas N.M. Induced sputum in the investigation of airway inflammation of COPD. Respir.Med. 2003; 97: 863–871.
30. Cohen J., Douma W.R., ten Hacken N.H. et al. Ciclesonide improves measures of small airway involvement in asthma. Eur.Respir. J. 2008; 31 (6): 1213–1220.
31. van Veen I.H., Sterk P.J., Schot R. et al. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur. Respir. J. 2006; 27: 951–956.
32. Kosciuch J., Krenke R., Gorska K. et al. Relationship between airway wall thickness assessed by high-resolution computed tomography and lung function in patients with asthma and chronic obstructive pulmonary disease. J. Physiol. Pharmacol.2009; 60 (Suppl. 5): 71–76.
33. Mikos M., Grzanka P., Sladek K. et al. Highresolution computed tomography evaluation of peripheral airways in asthma patients: comparison of focal and diffuse air trapping.Respiration 2009; 77: 381–388.
34. de Jong P.A., Muller N.L., Pare P.D., Coxson H.O. Computed tomographic imaging of the airways: relationship to structure and function. Eur. Respir. J. 2005; 26: 140–152.
35. Awadh N., Muller N.L., Park C.S. et al. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax 1998; 53: 248–253.
36. Goldin J.G., Tashkin D.P., Kleerup E.C. et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways:assessment with functional helical thinsection computed tomography. J. Allergy Clin. Immunol. 1999; 104: 258–267.
37. Kauczor H.U., Chen X.J., van Beek E.J., Schreiber W.G.Pulmonary ventilation imaged by magnetic resonance: at the doorstep of clinical application. Eur. Respir. J. 2001; 17:1008–1023.
38. Samee S., Altes T., Powers P. Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance:assessment of response to methacholine and exercise challenge.J. Allergy Clin. Immunol. 2003; 111: 1205–1211.
39. Fain S.B., Korosec F.R., Holmes J.H. et al. Functional lung imaging using hyperpolarized gas MRI. J. Magn. Reson.Imaging. 2007; 25: 910–923.
40. Bai T.R., Knight D.A. Structural changes in the airways in asthma: observations and consequences. Clin. Sci. (Lond.) 2005;108: 463–477.
41. Boxall C., Holgate S.T., Davies D.E. The contribution of transforming growth factorβ and epidermal growth factor signaling to airway remodelling in chronic asthma. Eur. Respir. J. 2006;27: 208–229.
42. Sutherland E.R., Martin R.J. Distal lung inflammation in asthma. Ann. Allergy Asthma Immunol. 2002; 89: 119–124.
43. Leach C.L., Davidson P.J., Boudreau R.J. Improved airway targeting with the CFCfree HFA-beclomethasone metered dose inhaler compared with CFC-beclomethasone. Eur. Respir. J.1998; 12: 1346–1353.
44. Powell H., Gibson P.G. Inhaled corticosteroid doses in asthma: an evidence-based approach. Med. J. Aust. 2003; 178 (5): 223–225.
45. Szefler S.J., Martin R.J., King T.S. et al. Significant variability in response to inhaled corticosteroids for persistent asthma.J. Allergy Clin. Immunol. 2002; 109 (3): 410–418.
46. Van Schayck C.P., Donnell D. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (pt 1): an update of clinical experience in adults. Int. J. Clin. Pract. 2004; 58: 678–688.
47. Hauber H.P., Taha R., Bergeron C. et al. Effects of hydrofluo-roalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients. Can. Respir. J.2006; 13: 73–78.
48. Bousquet J. Introduction. Modulite: simplifying the changeover.Respir. Med. 2002; 96 (Suppl. D): S1–S2.
49. Huchon G., Magnussen H., Chuchalin A. et al. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir. Med. 2009; 103 (1): 41–49.
50. Papi A., Paggiaro P.L., Nicolini G. et al. Bеclomethasone / formoterol versus budesonide / formoterol combination therapy in asthma. Eur. Respir. J. 2007; 29: 682–689.
51. Papi A., Paggiaro P., Nicolini G. et al. Beclomethasone / formoterol vs fluticasone / salmeterol inhaled combination in moderate to severe asthma. Allergy 2007; 62: 1182–1188.
52. Ильина Н.И., Павлова К.С. Эффективность и безопасность препарата Фостер у больных бронхиальной астмой в реальной клинической практике. Росс. аллерголог. Журнал 2010; 5: 82–90.
Review
For citations:
Budnevsky A.V., Burlachuk V.T., Olysheva I.A., Tokmachev E.V. OPPORTUNITY TO CONTROL ASTHMA: A ROLE OF SMALL AIRWAYS. PULMONOLOGIYA. 2011;(2):101-108. (In Russ.) https://doi.org/10.18093/0869-0189-2011-0-2-101-108
Views:
906
Email this article 